vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and TIDEWATER INC (TDW). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $336.8M, roughly 1.5× TIDEWATER INC). TIDEWATER INC runs the higher net margin — 65.3% vs 6.8%, a 58.5% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -2.4%). Over the past eight quarters, TIDEWATER INC's revenue compounded faster (2.4% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Tidewater, Inc. is a publicly traded international petroleum service company headquartered in Houston, Texas, U.S. It operates a fleet of ships, primarily providing vessels and marine services to the offshore petroleum and offshore wind industries.
MD vs TDW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $336.8M |
| Net Profit | $33.7M | $219.9M |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 19.0% |
| Net Margin | 6.8% | 65.3% |
| Revenue YoY | -1.7% | -2.4% |
| Net Profit YoY | 10.5% | 495.8% |
| EPS (diluted) | $0.40 | $4.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $336.8M | ||
| Q3 25 | $492.9M | $341.1M | ||
| Q2 25 | $468.8M | $341.4M | ||
| Q1 25 | $458.4M | $333.4M | ||
| Q4 24 | $502.4M | $345.1M | ||
| Q3 24 | $511.2M | $340.4M | ||
| Q2 24 | $504.3M | $339.2M | ||
| Q1 24 | $495.1M | $321.2M |
| Q4 25 | $33.7M | $219.9M | ||
| Q3 25 | $71.7M | $-806.0K | ||
| Q2 25 | $39.3M | $72.9M | ||
| Q1 25 | $20.7M | $42.7M | ||
| Q4 24 | $30.5M | $36.9M | ||
| Q3 24 | $19.4M | $46.4M | ||
| Q2 24 | $-153.0M | $50.4M | ||
| Q1 24 | $4.0M | $47.0M |
| Q4 25 | 9.9% | 19.0% | ||
| Q3 25 | 13.8% | 18.4% | ||
| Q2 25 | 12.8% | 23.7% | ||
| Q1 25 | 7.0% | 22.5% | ||
| Q4 24 | 7.8% | 23.6% | ||
| Q3 24 | 6.6% | 20.6% | ||
| Q2 24 | -31.3% | 23.0% | ||
| Q1 24 | 3.2% | 25.5% |
| Q4 25 | 6.8% | 65.3% | ||
| Q3 25 | 14.5% | -0.2% | ||
| Q2 25 | 8.4% | 21.4% | ||
| Q1 25 | 4.5% | 12.8% | ||
| Q4 24 | 6.1% | 10.7% | ||
| Q3 24 | 3.8% | 13.6% | ||
| Q2 24 | -30.3% | 14.8% | ||
| Q1 24 | 0.8% | 14.6% |
| Q4 25 | $0.40 | $4.37 | ||
| Q3 25 | $0.84 | $-0.02 | ||
| Q2 25 | $0.46 | $1.46 | ||
| Q1 25 | $0.24 | $0.83 | ||
| Q4 24 | $0.37 | $0.70 | ||
| Q3 24 | $0.23 | $0.87 | ||
| Q2 24 | $-1.84 | $0.94 | ||
| Q1 24 | $0.05 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $578.8M |
| Total DebtLower is stronger | $570.5M | $670.1M |
| Stockholders' EquityBook value | $865.9M | $1.4B |
| Total Assets | $2.2B | $2.4B |
| Debt / EquityLower = less leverage | 0.66× | 0.49× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $578.8M | ||
| Q3 25 | $340.1M | $428.2M | ||
| Q2 25 | $224.7M | $369.4M | ||
| Q1 25 | $99.0M | $341.8M | ||
| Q4 24 | $229.9M | $324.9M | ||
| Q3 24 | $103.8M | $280.8M | ||
| Q2 24 | $19.4M | $315.9M | ||
| Q1 24 | $8.0M | $280.9M |
| Q4 25 | $570.5M | $670.1M | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | $647.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $1.4B | ||
| Q3 25 | $890.7M | $1.1B | ||
| Q2 25 | $833.8M | $1.1B | ||
| Q1 25 | $789.2M | $1.1B | ||
| Q4 24 | $764.9M | $1.1B | ||
| Q3 24 | $732.5M | $1.1B | ||
| Q2 24 | $706.5M | $1.1B | ||
| Q1 24 | $856.2M | $1.1B |
| Q4 25 | $2.2B | $2.4B | ||
| Q3 25 | $2.2B | $2.1B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.0B | $2.1B | ||
| Q4 24 | $2.2B | $2.1B | ||
| Q3 24 | $2.1B | $2.0B | ||
| Q2 24 | $2.0B | $2.1B | ||
| Q1 24 | $2.2B | $2.1B |
| Q4 25 | 0.66× | 0.49× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | 0.58× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $153.0M |
| Free Cash FlowOCF − Capex | — | $147.8M |
| FCF MarginFCF / Revenue | — | 43.9% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | 3.39× | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $353.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $153.0M | ||
| Q3 25 | $137.3M | $54.7M | ||
| Q2 25 | $137.2M | $85.4M | ||
| Q1 25 | $-117.5M | $86.0M | ||
| Q4 24 | $133.0M | $100.0M | ||
| Q3 24 | $91.8M | $49.0M | ||
| Q2 24 | $107.0M | $78.6M | ||
| Q1 24 | $-125.2M | $54.8M |
| Q4 25 | — | $147.8M | ||
| Q3 25 | — | $49.6M | ||
| Q2 25 | — | $80.2M | ||
| Q1 25 | — | $75.7M | ||
| Q4 24 | — | $95.5M | ||
| Q3 24 | — | $43.3M | ||
| Q2 24 | — | $72.3M | ||
| Q1 24 | — | $43.8M |
| Q4 25 | — | 43.9% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 23.5% | ||
| Q1 25 | — | 22.7% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | — | 21.3% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | 3.39× | 0.70× | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 1.17× | ||
| Q1 25 | -5.66× | 2.02× | ||
| Q4 24 | 4.36× | 2.71× | ||
| Q3 24 | 4.72× | 1.06× | ||
| Q2 24 | — | 1.56× | ||
| Q1 24 | -31.03× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
TDW
Segment breakdown not available.
